CXCL4-induced macrophages in human atherosclerosis

Area of Science:

• Cardiovascular Biology
• Immunology
• Inflammation Research

Background:

• Atherosclerosis is an inflammatory arterial disease where monocytes and platelets are key players.
• Monocytes differentiate into macrophages, internalize lipids, form foam cells, and release pro-inflammatory cytokines.
• Platelets secrete chemokines that mediate inflammatory and immune responses in atherogenesis.

Purpose of the Study:

• To review the role of platelet factor-4 (PF4) in monocyte and macrophage biology within atherosclerosis.
• To elucidate the formation and characteristics of PF4-induced M4 macrophages.
• To explore the diagnostic and therapeutic potential of M4 macrophages in atherosclerotic disease.

Main Methods:

• Review of existing literature on PF4, monocytes, macrophages, and atherosclerosis.
• Analysis of PF4's interaction with monocytes and endothelial cells.
• Identification and characterization of a novel macrophage phenotype (M4) induced by PF4.
• Validation of M4 macrophage markers (CD68, S100A8, MMP7) in vitro and in vivo.

Main Results:

• PF4, in conjunction with CCL5, promotes monocyte adhesion to endothelial cells and subsequent diapedesis.
• PF4 induces a unique macrophage phenotype, termed "M4," characterized by the loss of CD163.
• M4 macrophages are identifiable by CD68, S100A8, and MMP7 and are found in atherosclerotic lesions.
• M4 macrophages are prevalent in the intima and adventitia of human atherosclerotic plaques and associated with plaque instability.

Conclusions:

• PF4-induced M4 macrophages represent a distinct pro-inflammatory cell population in atherosclerosis.
• The presence and characteristics of M4 macrophages correlate with plaque instability.
• M4 macrophages present a promising target for future diagnostic and therapeutic strategies in managing atherosclerotic disease.